Recent Finacing
Recent Raise
Qvanteq develops a bioactive, coating-free surface technology for coronary stents that accelerates endothelialization and reduces restenosis versus bare-metal stents, with potential to shorten dual antiplatelet therapy.
Focus Areas
Total Raised
Funding round